# Ishihara Sangyo Kaisha, Ltd. – FDA Inspection, Sep 8, 2017

Source: https://www.keypedia.com/records/fda_inspections/ishihara-sangyo-kaisha-ltd/92560ad6-febf-447e-8d8a-e7dc9a35caf0
Source feed: FDA_Inspections

> FDA inspection 1028577 of Ishihara Sangyo Kaisha, Ltd., September 08, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028577
- Company Name: Ishihara Sangyo Kaisha, Ltd.
- Inspection Date: 2017-09-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1181874 - 2022-09-09
- FDA Inspection 895933 - 2014-09-05
- FDA Inspection 747053 - 2011-09-02

## Related Officers

- [Christopher S. Keating](https://www.keypedia.com/people/christopher-s-keating/94fcfd32-feb5-4b6c-80da-16202f4be01d)

Company: https://www.keypedia.com/companies/ishihara-sangyo-kaisha-ltd/ccb80b55-c2c2-466b-aaae-76f386802655

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c